FACT SHEET Biometrics Biometrics are the backbone of the drug development process, and our global Biometrics group understands how to use the power of data-driven decision making to deliver high-quality services from development through to market launch and beyond. By employing tested technologies and approaches, we support clients’ projects with a time-tested operational model, while providing insightful access to study data, metrics, and industry-standard delivery models. Executive Summary The biometrics landscape is changing, and the need for expert design, analytics, risk- management and data coordination is more critical than ever. Our patient-centered team understands the importance of high-quality data with optimal statistical design, ongoing risk management/mitigation and ra

Join for free to read